Global Safety Needles Market to Reach US$ 8,000 Mn by 2027 End - Future Market Insights

Valley Cottage, NY, December 4, 2017 (Newswire.com) - North America is the largest market while Asia Pacific Excluding Japan is the fastest growing market in the global safety needles market

The global safety needles market is estimated to be valued at nearly US$ 4,000 Mn in 2017 and is anticipated to touch almost US$ 8,000 Mn by 2027 end, registering a CAGR of 6.9 % over the forecast period. North America is the largest regional market, which is estimated to cross US$ 1,200 Mn, or 31.1% share of the total market share in 2017 and is estimated to reach a market valuation in excess of US$ 2,500 Mn by 2027, registering a CAGR of 7.3% over the forecast period. APEJ is the fastest growing market, which is expected to grow from nearly US$ 540 Mn in 2017 to over US$ 1,100 Mn by 2027.

As the global safety needles market is replete with continuous new innovative technology and novel product launches, companies in the safety needles market across the world are actively engaged in the process of mergers and acquisitions in order to strengthen their product portfolio and cement their position in the market. Top market players are adopting the strategy of mergers and acquisitions to enhance their brand value and to develop more effective and efficient products while meeting the global standards for safety and efficiency. This will help companies increase their market share and expand their consumer base in uncharted territories.

Get a Sample of this Research Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2029

Strategic acquisition case study – Boston Scientific and Xlumena Inc.

In 2015, Boston Scientific reached an agreement announcing the acquisition of Xlumena, a company that manufactures minimally invasive devices to carry out endoscopic ultrasound (EUS) enabled transluminal drainage of specific target areas in the gastrointestinal tract. According to the terms and conditions of the deal, besides an initial upfront payment, Boston Scientific shall also pay an additional amount to Xlumena once the FDA gives clearance to Xlumena’s HOT AXIOS device. In addition, sales milestones as per volume sales achieved in 2018 are also a part of the deal. The advanced HOT AXIOS Stent and Delivery System integrates cautery in the AXIOS stent that has been approved by the FDA. This strategic acquisition will help Boston Scientific establish its stronghold in the EUS segment.

Worldwide safety legislations regarding safety needles

In the year 1991, the Blood Borne Pathogen standard was established in the U.S. 1999 was a landmark year as anti-needlestick legislation was implemented in California, U.S. In the year 2000, Federal Anti-Needlestick legislation was passed in the U.S. In 2005, order 827/2005 was set by the Ministry of Health in Spain. In 2007, the National Health Service Reference Guide was implemented in the U.K. In the same year, Sharp Injury Protection was legislated in Germany. In 2008, Sharp Injury Protection was legislated in Canada. In the year 2010, a legislation was passed in Brazil regarding needlestick injuries. In 2011, the Amendment to Medical Care Act was passed in Taiwan that takes into account needlestick injuries. The year 2013 was the deadline for Sharps Legislation implementation in the European Union. More countries are expected to follow soon and enact legislations regarding needlestick injuries and their prevention. 

Government enforcement to use safety needles in various countries likely to give a boost to the global safety needles market

In order to avoid hospital acquired diseases such as HIV, Hepatitis C and Hepatitis B etc., governments in various countries are implementing stringent regulations as mentioned above. Needlestick injuries sustained from contaminated needles can result in infections from various harmful blood borne diseases. As per a report by the Program for Appropriate Technology in Health (PATH) published in 2005, due to the reuse of contaminated needles, 2 Mn Hepatitis C infections, 20 Mn Hepatitis B infections and 250,000 HIV infections are caused annually. Various government supported norms such as Needlestick Safety and Prevention Act, Needles Exchange Program and implementation of OSHA’s blood borne pathogens standards are increasing awareness among the population about diseases caused by using contaminated needles, and this factor is likely to fuel the demand for better quality safety needles.  

Get full Research Report from here: https://www.futuremarketinsights.com/checkout/2029

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): +44(0)20-7692-8790
Sales: sales@futuremarketinsights.com
Website: http://www.futuremarketinsights.com

Source: Future Market Insights